Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
188 INR | +13.22% |
|
+18.20% | +16.69% |
02/07 | Marksans Pharma Gets UK Regulator's Nod for Two Products | MT |
31/05 | Transcript : Marksans Pharma Limited, Q4 2024 Earnings Call, May 31, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.69% | 1.02B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- MARKSANS Stock
- News Marksans Pharma Limited
- Marksans Pharma Gets UK Regulator's Nod for Two Products